Investors MIG, Santo Venture Capital and Digital Health Ventures have acquired a significant minority stake in the transaction. Liva Healthcare is already backed by Danish Maj Invest.
Kristoffer From, CEO of Liva Healthcare, said: “This investment is rocket fuel for Liva Healthcare.
“It enables our ambition of expanding internationally and helping even more patients to prevent and manage their chronic conditions through personal coaching and lifestyle changes.
“We are looking forward to working with our three new German investors in driving further growth.”
Liva Healthcare’s digital platform is used by a broad range of healthcare organisations across Northern Europe to prevent and manage chronic diseases such as Type 2 diabetes and heart disease through lifestyle changes.
Among Liva’s most prominent customers since December 2017 are NHS England, which uses the platform to fight the obesity and diabetes epidemics.
Also, several health authorities in Scandinavia have selected Liva Healthcare for disease management and patient education across a spectrum of lifestyle conditions.
In addition to working with public and private healthcare providers and payers, Liva Healthcare is also engaged with major global pharma companies. Here, the innovative company is combining personal lifestyle coaching with medications to drive better and more sustainable outcomes.
MIG partner Sören Hein said: “We have been very impressed by the proven clinical outcomes and efficiency of Liva Healthcare’s platform. The platform is making it possible to scale personal coaching and health professional-centred disease management.
“Early successes with leading healthcare players show that Liva Healthcare is already in a special league. Clients recognise that Liva Healthcare offers a cost-effective solution with an attractive return-on-investment.
“We are thrilled to support the company financially in its growth ambitions, not least given the potential to work with major pharmaceutical firms to combine medicine with scalable digital coaching.”